An interventional study of TEEN LENS and Usual Care in Suicidal Ideas, Suicidal Ideation and Suicidal Thoughts, sponsored by University of Colorado, Denver. Not yet recruiting. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Treatment
The purpose of this study is to test whether a lethal means safety planning intervention, TEEN LENS ED, is acceptable to teens at elevated suicide risk and their caregivers in the Emergency Department.
569 studies on the registry are indexed under Suicidal Ideation; 203 are open to participants now.
This study's planned enrollment of 200 is above the median of 80 across 469 interventional studies indexed under Suicidal Ideation.
Browse Suicidal Ideation studies →University of Colorado, Denver is the lead sponsor of 1,543 studies on the registry; 317 are open to participants now.
Of its 147 completed or terminated interventional studies of FDA-regulated products, 92 (63%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Teens (13-17 years old) presenting to the Children's Hospital Colorado Emergency Department (ED) with a non-mental health related complaint, and with a non-acute positive suicide screen (using the validated Ask Suicide Screening Questions questionnaire).
For inclusion, participants must be:
Exclusion Criteria:
Participants will receive a list of mental health resources in the Emergency Department prior to discharge.
Behavioral: Usual Care
Participants will receive a tablet-based lethal means safety planning intervention (TEEN LENS) and a list of mental health resources in the Emergency Department prior to discharge.
Behavioral: TEEN LENS
Single tablet-based intervention to support lethal means safety planning.
Standard list of mental health resources and crisis phone numbers.
Acceptability among teens
Acceptability among teens during the intervention versus control period using the composite score from the adapted validated Client Satisfaction Questionnaire (CSQ-8), where higher scores indicate increased acceptability.
Time frame: Within 48 hours of receipt of care (intervention or control).
Acceptability among caregivers
Acceptability among caregivers during the intervention versus control period using the composite score from the adapted validated Client Satisfaction Questionnaire (CSQ-8), where higher scores indicate increased acceptability.
Time frame: Within 48 hours of receipt of care (intervention or control).
Provider perceived acceptability
Provider perceived acceptability of using TEEN LENS ED using the validated Acceptability of Intervention Measure (AIM), a composite score where higher scores indicate higher acceptability.
Time frame: From start of the intervention period until end of the intervention period (6 months).
Provider perceived appropriateness
Provider perceived appropriateness using the validated Intervention Appropriateness Measure (IAM), a composite score where higher scores indicate higher appropriateness.
Time frame: From start of the intervention period until end of the intervention period (6 months).
Provider perceived feasibility
Provider perceived feasibility using the validated Feasibility of Intervention Measure (FIM), a composite score where higher scores indicate higher feasibility.
Time frame: From start of the intervention period until end of the intervention period (6 months).
Feasibility of follow up
Proportion of participants who complete baseline surveys that complete follow up.
Time frame: From enrollment to follow up at 2 months.
No study locations are listed for this record.
Plan to share: Yes — All collected IPD will be shared after removing any data that may be identifying.
Supporting information: Study protocol, Informed consent form
Time frame: Supporting documentation will be made available one year after publication of the first paper and will have no end date.
Access criteria: All data will be publicly available at the University of Michigan sponsored Inter-university Consortium for Political and Social Research (ICPSR) under the Institute for Firearm Injury Prevention data collection (https://www.icpsr.umich.edu/sites/ifip/home)
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Colorado, Denver →